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Sonja Zeilinger4, Norman Klopp5, Thomas Illig5, Katharina Schramm6, Holger Prokisch6, Brigitte Ku¨hnel7,
Christian Gieger7, Ju¨rgen Harder1, Liliana Cifuentes3, Natalija Novak8 and Stephan Weidinger1
Epigenetic alterations are increasingly recognized as mechanisms for disease-associated changes in genome
function and important risk factors for complex diseases. The epigenome differs between cell types and so far
has been characterized in few human tissues only. In order to identify disease-associated DNA methylation
differences for atopic dermatitis (AD), we investigated DNA from whole blood, T cells, B cells, as well as lesional
and non-lesional epidermis from AD patients and healthy controls. To elicit functional links, we examined
epidermal mRNA expression profiles. No genome-wide significant DNA methylation differences between AD
cases and controls were observed in whole blood, T cells, and B cells, and, in general, intra-individual differences
in DNA methylation were larger than interindividual differences. However, striking methylation differences were
observed between lesional epidermis from patients and healthy control epidermis for various CpG sites, which
partly correlated with altered transcript levels of genes predominantly relevant for epidermal differentiation and
innate immune response. Significant DNA methylation differences were discordant in skin and blood samples,
suggesting that blood is not an ideal surrogate for skin tissue. Our pilot study provides preliminary evidence for
functionally relevant DNA methylation differences associated with AD, particularly in the epidermis, and
represents a starting point for future investigations of epigenetic mechanisms in AD.
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INTRODUCTION
Atopic dermatitis (AD) is a common chronic inflammatory
skin disease characterized by epidermal barrier dysfunction
and immunological alterations. It is strongly genetically as
well as environmentally triggered (Bieber, 2008). Although a
number of risk genes for AD have been established in the past
years, only 14.4% of the estimated total heritability can be
explained so far (Ellinghaus et al., 2013). One additional but
potentially underestimated source of this hidden heritability
might be represented by epigenetic mechanisms (Johannes
et al., 2009).
Epigenetics refers to functionally relevant changes in a
chromosome without alterations in the DNA sequence, which
critically contributes to phenotypic plasticity. The most widely
studied epigenetic mechanism is the cytosine methylation of
DNA, which is essential in cell-lineage specification, in the
regulation of transcription, and in the maintenance of genome
stability (Jones, 2012). Individual DNA methylation patterns
are largely established during embryonic development
through a highly coordinated process and considered to be
relatively stable. Thus, the pre- and perinatal period is a
critical window for epigenetic alterations with high sensitivity
to environmental exposures affecting many cell types (Martino
and Prescott, 2010). However, DNA methylation in part is
dynamic, and epidemiological studies on skin and other
tissues identified locus- and cell type-specific DNA
methylation changes associated with various environmental
factors, including chronic exposure to sunlight, asbestos, and
ORIGINAL ARTICLE
1Department of Dermatology, Allergology, and Venereology, University
Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany; 2Graduate School
of Information Science in Health (GSISH), Technische Universita¨t Mu¨nchen,
Munich, Germany; 3Department of Dermatology and Allergology, Klinikum
am Biederstein, Technische Universita¨t Mu¨nchen, Munich, Germany;
4Research Unit of Molecular Epidemiology, Helmholtz Zentrum Mu¨nchen,
German Research Center for Environmental Health, Neuherberg, Germany;
5Hannover Unified Biobank, Hannover Medical School, Hannover, Germany;
6Institute of Human Genetics, Helmholtz Zentrum Mu¨nchen, German
Research Center for Environmental Health, Neuherberg, Germany; 7Institute of
Genetic Epidemiology, Helmholtz Zentrum Munchen, German Research
Center for Environmental Health, Neuherberg, Germany and 8Department of
Dermatology, University of Bonn, Bonn, Germany
Correspondence: Stephan Weidinger, Department of Dermatology,
Allergology, and Venereology, University Hospital Schleswig-Holstein,
Campus Kiel, Schittenhelm Street 7, 24103 Kiel, Germany.
E-mail: sweidinger@dermatology.uni-kiel.de
9These authors contributed equally to this work.
Received 4 September 2013; revised 29 January 2014; accepted 29 January
2014; accepted article preview online 13 February 2014; published online
17 April 2014
Abbreviations: AD, atopic dermatitis; AL, AD lesional; AN, AD non-lesional;
DET, differentially expressed transcript; DMS, differentially methylated site;
FLG, filaggrin; GO, Gene Ontology; NN, control healthy; OAS2, 20-50-
oligoadenylate synthetase 2; qPCR, quantitative PCR
& 2014 The Society for Investigative Dermatology www.jidonline.org 1873
tobacco smoke, consumption of alcohol, and use of hair dye
(Christensen et al., 2009; Gronniger et al., 2010; Langevin
et al., 2011). Therefore, it is likely that DNA methylation
serves as an important mediator between the environment and
genome regulation also in postnatal life.
So far, epigenetic mechanisms have mostly been studied in
cancer, but are increasingly recognized as an important factor
influencing the individual risk for complex diseases such as
AD or asthma (Miller and Ho, 2008). To our best knowledge,
only three studies on AD-specific epigenetic risk factors have
been conducted so far. Nakamura et al. (2006) reported a
significantly reduced expression of DNA methyltransferase 1
(DNMT1) in peripheral blood mononuclear cells of AD-
affected individuals with high serum IgE levels. DNA
methyltransferase 1 is considered to be the key enzyme for
maintenance of DNA methylation patterns during cell
division, but it also seems to have substantial de novo DNA
methylation capability and malfunction of this enzyme may
lead to modified DNA methylation and consequently skewed
expression of AD-related genes. Liang et al. (2012) observed
hypomethylation of the local high-affinity IgE receptor gamma
subunit (FCER1G) promoter in monocytes from AD patients to
be correlated with increased gene expression. A recent
analysis of methylation levels of CpG sites across the
filaggrin (FLG) gene in DNA from peripheral blood of 245
female individuals, 37 of whom had AD ever, showed no
significant differences between carriers and noncarriers of FLG
mutations, but a potential interaction between FLG variants
and methylation at a single CpG site in the FLG gene body
(Ziyab et al., 2012). However, the validity and functional
relevance of this observation, and the situation in skin, where
FLG is expressed, are unclear.
In the current epigenome-wide association study, we
investigated 28 AD-affected and 29 healthy individuals for
methylation changes of DNA derived from lesional (AL) and
non-lesional (control healthy (NN)/AD non-lesional (AN) for
healthy controls/AD patients) epidermis, whole blood, T cells,
and B cells. To explore potential functional links, a genome-
wide RNA expression analysis in NN, AL, and AN was
implemented, and both data sets were analyzed in an
integrated manner. Technical validation of significant DNA
methylation and RNA expression array results was performed
with the EpiTyper MassARRAY system and quantitative PCR
(qPCR), respectively.
RESULTS
DNA methylation patterns are highly tissue specific
For methylome analysis, we applied the Human Methylation27
BeadChip in order to capture the methylation status of 27,578
single CpG sites in NN, AL, and AN epidermis, whole blood, T
cells, and B cells in a total of 28 AD patients and 29 controls.
For details on the study population and biosamples see Table 1.
A principal component analysis of 25,648 autosomal CpG
sites in epidermal samples, whole blood, T cells, and B cells
showed explicit clustering for the different tissues. Epidermal
tissue can be clearly distinguished from the different blood cell
types, which closely cluster together (Supplementary Figure S1
online). To determine interindividual and intra-individual
DNA methylation differences, we calculated pairwise
correlation between individuals of an age- and sex-
matched subsample (n¼4) across all methylation sites within
the same tissue as well as pairwise correlation between
different tissues within the same individual (Supplementary
Figures S2 and S3 online). We observed stronger correlations
within the same tissue between different individuals
than between different tissues within the same individual.
Thus, our analysis in four different tissues indicates a
high tissue-specificity for DNA methylation patterns in accor-
dance with the literature (Illingworth et al., 2008; Varley
et al., 2013).
Differentially methylated CpG sites in epidermal DNA
In the pairwise comparisons of AL/NN (n¼25/28), AL/AN
(n¼ 16), and AN/NN (n¼17/28), we observed 127, 47, and
7 differentially methylated sites (DMSs) reaching a liberal
significance threshold of Po0.001 and a methylation differ-
ence of at least 10% (|Db|40.10) (Supplementary Table S1
online). No strong tendency toward hypo- or hypermethyla-
tion (47% and 53%, respectively) for disease-associated
CpGs could be detected. Functional clustering of the AL/NN-
DMS-allocated genes with DAVID (Huang da et al., 2009a, b)
revealed a significant (Benjamini Hochberg corrected
PBHo2.910 2) enrichment of the cellular component
terms ‘‘integral/intrinsic to plasma membrane’’ (Gene Onto-
logy (GO): 0031226; 0005887). No significant GO term
enrichment could be detected for AL/AN and AN/NN genes.
However, six of the AL/AN genes with DMS were grouped to
the molecular function term ‘‘structural molecule activity’’
(GO: 0005198), e.g., desmin and the epidermal differen-
tiation complex gene involucrin, possibly pointing toward an
epigenetic influence on the epidermal barrier function related
to inflammation.
In all, 11 DMS from the AL/NN analysis reached conserva-
tive Bonferroni-corrected genome-wide significance (Po1.9
 10 6) and were selected for technical validation using the
Table 1. Characteristics of the study cohort
Study cohort
Variable AD (n¼28) Controls (n¼ 29)
Female, n (%) 13 (46.4) 15 (51.7)
Median age, years (range) 38.5 (20–62) 27 (22–69)
Epidermal methylation data, n (%)
Lesional 25 (89.3) –
Non-lesional 17 (60.7) 28 (96.6)
Epidermal expression data, n (%)
Lesional 12 (42.9) –
Non-lesional 7 (25) 14 (48.3)
Methylation whole blood, n (%) 12 (42.9) 13 (44.8)
Methylation B cells, n (%) 11 (39.3) 12 (41.4)
Methylation T cells, n (%) 12 (42.9) 13 (44.8)
Abbreviation: AD, atopic dermatitis.
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Sequenom Epityper. In addition, we selected two CpGs with
P-values marginally below the Bonferroni threshold
(Po3.0106) and |Db|40.10, as well as three CpGs
with a |Db|40.20 and a P-value of o10 5 between AL and
NN for validation. Thus, a total of 16 CpGs were reanalyzed in-
depth with the Sequenom EpiTyper approach. Nine CpGs
could be validated, showing a significant association (Bonfer-
roni-corrected significance threshold P¼ 0.003) with AD as
well as a high correlation between methylation values as
measured by the two different methods (Supplementary Table
S2 online).
CpGs located within or next to the genes CFLAR, GPR55,
MMP7, LOC283487, SH2D2A, and ERP27 were hypomethyl-
ated, whereas CpGs assigned to LRRC8C, S100A5, and EBP49
were hypermethylated in AD patients (Table 2). The strongest
association (P¼ 3.49 10 8) and the maximum difference in
methylation (Db¼0.44) was observed for cg06641366
located within a CpG island N shore in the promoter region
of LRRC8C. All EpiTyper assays were designed in order to
allow us regional finemapping of additional CpG sites within a
region of 300–400bp around the associated CG dinucleotide.
For three of the identified loci (LRRC8C, GPR55, MMP7),
485% of fine-mapped CpGs revealed significant associations.
All analyzed CpGs in the promoter region of the gene LRRC8C
and within exon 1 of MMP7, and 12 of 14 CpGs within intron
1 of GPR55 showed P-values o0.003, whereas in the
remaining loci (S100A5, CFLAR, EBP49, LOC283487,
SH2D2A, ERP27) only the CpG identified in the screen or
one or two directly neighboring CpG sites were associated.
Associated CpGs within a certain locus showed broad ranges
of median methylation differences of 9–60% between AL
and NN (Supplementary Figure S6 online; Supplementary
Table S2 online).
Two of the significantly associated sites (LRRC8C and
EPB49) in AL versus NN additionally showed a nominal
association (Po103, Db¼ 0.20, and Db¼0.13, respectively)
between AL and AN (Supplementary Figure S4 online),
whereas no association was seen for AN versus NN
(PLRRC8C¼0.7225, PEPB49¼0.7508). Both associations could
be technically validated (P¼0.00083, Db¼0.33 and
P¼0.0011, Db¼0.26, respectively, Supplementary Table S2
online), and the fine mapping showed an additionally asso-
ciated neighboring CpG for LRRC8C (P¼0.00018, Db¼ 0.35).
In contrast, a single CpG site assigned to the gene ERP27
showed clear methylation differences with nominal signifi-
cance (Po103) for AL (Db¼ 0.26, P¼6.3106) and for
AN (Db¼ 0.20, P¼ 8.02 10 4) compared with those in
NN, but not between AL and AN within cases (P¼ 0.16),
Table 2. Differentially methylated sites between AL and NN
CpG Chr
Position
hg19 Gene
CpG
location1 P value
Medianmeth
(AL)
Medianmeth
(NN)
Medianmeth
difference GO term (b.p., m.f., c.c.)
cg06641366 1 90097604 LRRC8C CGI N shore 3.49 108 0.775 0.334 0.441 Integral to membrane (c.c.), endoplasmic
reticulum membrane (c.c.)
cg08823182 1 153514482 S100A5 Promoter 7.19 106 0.566 0.341 0.225 Protein homodimerization activity (m.f.),
calcium/copper/zinc ion binding (m.f.),
nucleus (c.c.)
cg20839149 1 156786601 SH2D2A CGI S shelf 2.14 106 0.138 0.434  0.296 Cell differentiation/proliferation (b.p.),
signal transduction (b.p.), SH3 domain
binding (m.f.), cytoplasm (c.c.)
cg18119407 2 201980504 CFLAR CGI N shore 1.86 106 0.300 0.512  0.212 Regulation of apoptotic/necroptotic
process (b.p.), positive regulation of IkB
kinase/NF-kB cascade (b.p.), cytoplasm
(c.c.)
cg20287234 2 231789465 GPR55 Intronic 1.80 106 0.231 0.536  0.305 G-protein coupled receptor signaling
pathway (b.p.), positive regulation of ERK1/
ERK2 cascade/Rho protein signal
transduction (b.p.), plasma membrane
(c.c.)
cg14706739 8 21916355 EPB49 CGI S shore 3.90 107 0.684 0.518 0.166 Cytoskeleton organization (b.p.), actin
binding (m.f.), cellular response to calcium
ion (b.p.)
cg25511807 11 102401438 MMP7 Exonic 1.38 106 0.204 0.443  0.239 Extracellular matrix organization (b.p.),
regulation of cell proliferation (b.p.),
antibacterial peptide secretion (b.p.),
metalloendopeptidase activity (m.f.),
extracellular region (c.c.)
cg13435792 12 15092434 ERP27 Promoter 6.30 106 0.437 0.701  0.263 Endoplasmic reticulum lumen (c.c.)
cg22131172 13 111522865 LOC283487 Promoter 1.33 106 0.175 0.365  0.190 —
Abbreviations: AL, AD lesional; b.p., biological process; c.c., cellular component; CGI, CpG island; Chr, chromosome; ERK, extracellular signal–regulated
kinase; GO, Gene Ontology; m.f., molecular function; NN, control healthy.
Sorted by chromosome.
1In relation to gene, GO terms are b.p., m.f., c.c..
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suggesting AD-specific relevance. Technical validation with
the EpiTyper in AN versus NN showed a Db of 0.39, but no
significant association (P¼0.006) for this CG dinucleotide.
We did not find any genome-wide significant median
methylation differences X10% between cases and controls
in DNA from whole blood, T cells, and B cells nor between
AN and NN (P41.0 10 4) or AL and AN (P43.0106).
A FLG mutation (R501X, 2282del4) stratified analysis for
our top DMS did not reveal significant differences between
carriers and noncarriers. Further, we did not observe signifi-
cant methylation differences of CpGs within FLG in any of the
tissues investigated.
Similarly, apart from hypomethylation of a site mapping to
IL23A (Db¼ 0.129, P¼0.00097) in AL/NN, which, how-
ever, did not correlate to any expression change, no DMS
significantly associated with AD located in genetic suscept-
ibility loci for psoriasis, AD, and asthma identified through
GWAS could be detected in any of the tissues (Supplementary
Table S3 online).
Differentially expressed epidermal mRNA
Genome-wide mRNA expression analysis using the
HumanHT-12v3 Expression BeadChip, which measures the
expression of425,000 coding and noncoding transcripts with
448,000 probes, revealed a total of 10,419 transcripts to be
expressed in the epidermis. In the pairwise comparisons of AL/
NN (n¼12/14), AL/AN (n¼6), and AN/NN (n¼7/14), 132,
90, and 398 transcripts showed suggestive evidence for
differential expression (Po0.001, fold change 41.3). Func-
tional enrichment analysis with DAVID presented a strongly
significant (PBHo104) enrichment of gene transcripts for
various GO terms related to epidermal differentiation within
the AL/NN analysis (Supplementary Table S4 online).
Seven transcripts showed genome-wide significant expres-
sion differences (Po4.8 10 6) between AL and NN, and
four additional transcripts between AN and NN (Supple-
mentary Table S5 online). Some of these transcripts are
involved in innate immune response, but we also detected
transcripts from genes with structural functions, e.g., late
cornified envelope genes located within the epidermal differ-
entiation complex.
Correlation of DNA methylation and mRNA expression in
epidermis
Across individual epidermal specimens with DNA methylation
as well as expression data available, we analyzed correlations
between DMS defined as |Db|40.1 and Po0.05 and differ-
entially expressed transcripts (DETs) defined as fold change
41.3 and Po0.05 located in-cis within a 200-kb distance
from the DMS. In the comparison of AL/NN, AL/AN, and AN/
NN, we observed 47, 2, and 10 DMS/DET pairs showing
Po0.01 and a correlation of at least |r|40.5 (Table 3). We did
not see any significant functional enrichment for correlated
DETs in the AL/AN and AN/NN analysis, whereas a large
proportion (425%) of correlated transcripts from AL/NN
comparison relates to S100A genes located within the epi-
dermal differentiation complex and to genes encoding keratins
located within the keratin clusters. Accordingly, a functional
analysis performed with DAVID in order to identify common
functional characteristics of correlated DETs showed a clear
enrichment of gene transcripts annotated to the cellular
component terms ‘‘keratin filament’’ (PBH¼2.4E-2,
GO:0045095), ‘‘intermediate filament cytoskeleton’’
(PBH¼ 2.6E-2, GO:0045111), and ‘‘intermediate filament’’
(PBH¼ 4.7E-2, GO:0005882; Figure 1). In addition, we
observed differential methylation of a CpG site within OAS2
(20-50-oligoadenylate synthetase 2), which was correlated with
expression levels of OAS1, OAS2, and OAS3.
From nine selected DMS/DET pairs fulfilling the more
stringent in-cis definition of±50kb, we successfully validated
AD-associated DNA methylation and RNA expression
changes as well as correlation for the six DMS/DET combina-
tions KRT6A/KRT6A, KRT6A/KRT6B, IFI27/IFI27, OAS2/OAS2,
GDPD3/GDPD3, and S100A5/S100A2 with the EpiTYPER and
qPCR (Supplementary Table S6 online).
Strong in-trans correlation was found for cg06641366
(LRRC8C) methylation with mRNA expression of CD36
(7q31.11; r¼ 0.842, P¼2.08106), which showed differ-
ential expression in AL and NN (Supplementary Figure S5
online), as well as cg14706739 (EPB49) methylation with
LCE3D and IFI27 mRNA expression (r¼ 0.821, P¼ 2.37
106; r¼0.823, P¼ 2.2710 6), which are located on 1q21.3
and 14q32.12, respectively (Supplementary Table S6 online).
DISCUSSION
Here we used a genome-wide approach to study previously
unreported DNA methylation and expression patterns in AD.
In our small-scale pilot study across several tissues, intra-
individual inter-tissue variation in DNA methylation by far
exceeded interindividual variation in any given tissue and
confirmed previous findings of a high tissue specificity of
DNA methylation (Zhang et al., 2013; Ziller et al., 2013). In
particular, epidermis and blood cells appear to have very
distinct methylomic profiles. Our analysis further indicates
that the key tissue influenced by epigenetic dysregulation in
AD may be the skin and that blood does not present an
adequate surrogate tissue for epidermis. Using conservative
significance thresholds and stringent criteria for methylation
degrees, several strong AD-associated differences were
observed in the DNA of epidermal specimen, but not in the
DNA from blood, T cells, or B cells. The lack of association in
the latter may be due to the heterogenous cell composition
of the samples, especially of whole blood, or due to small
sample sizes. To rule out bias through inflammatory infiltrates
in AL epidermal shaves (Suarez-Farinas et al., 2013), we
checked for expression of T cell–specific CD3 genes (CD3a,
CD3e, and CD3g units). Very low expression levels reaching
o50% of the minimum magnitude found in blood were
detected for CD3 E and D in five epidermal samples (three
cases and two controls) only, whereas CD3G could not be
detected in any epidermal sample, indicating that ‘‘contam-
ination’’ by infiltrating immune cells was not a major issue.
In the isolated analysis of methylation, the CpGs found to
exhibit the strongest AD-associated signatures are located in or
near plasma membrane genes, a functionally very divergent
group including, e.g., ion channels, signal transducers, and
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structural proteins. ‘‘Fine mapping’’ of these loci often
revealed further DMS within 400bp around the initial CpG
to be associated with AD. Further, in contrast to common
assumptions (Barrera and Peinado, 2012), methylation patterns
across neighboring CpGs within a certain region were not
always consistent (Supplementary Figure S6 online). Methyla-
tion patterns were not associated with FLG genotypes, and
there were no DMS within the FLG gene, indicating that FLG
is not the subject of epigenetic regulation in AD.
Relevant correlations of DNA methylation and RNA expres-
sion were mainly restricted to the AL/NN analysis, but high
numbers of transcripts exhibiting expression changes between
AL/AN and AN/NN indicate disease-associated differences
between uninvolved, involved, and healthy epidermis, which,
however, might be regulated by mechanisms other than DNA
methylation. An integrated analysis of both DNA methylation
and mRNA expression data from epidermal specimen
revealed several sites differently methylated between cases
and controls, which were correlated with altered expression
levels of transcripts in cis. In addition, we observed some trans
effects. Although we acknowledge that these must be inter-
preted with great caution, there is increasing evidence for the
existence of interchromosomal regulatory mechanisms
between DNA methylation and gene expression (van Eijk
et al., 2012). Most CpG/transcript pairs displayed an inverse
correlation, i.e., higher methylation levels were associated
with lower expression and vice versa, which is commonly
observed in CpG islands close to transcription start sites where
DNA methylation is associated with long-term silencing of the
according gene. However, we also observed positive
correlations, which is in line with results from other studies,
in particular on sites outside of CpG islands or within gene
bodies (Jones, 1999; Gibbs et al., 2010; Bell et al., 2011).
The majority (425%) of correlated transcripts from the AL/
NN comparison mapped to S100A genes located within the
epidermal differentiation complex or to genes encoding
keratins located within the keratin clusters. S100 proteins are
known to be key players in epidermal inflammatory processes
with multiple functions including regulation of keratinocyte
proliferation and maturation, antimicrobial defense, and self-
danger signaling (Halawi et al., 2013). Keratins belong to a
family of epithelial cytoskeleton proteins and in general are
important for the structural integrity of epithelial tissue. Apart
from their mechanical roles, some keratins are also involved in
intracellular signaling pathways (Moll et al., 2008).
Our analysis confirms the known overexpression of
S100A2, A7, A8, A9, and A15 (alias S100A7A) in lesional
skin of AD patients (Suigura et al., 2005; Wolf et al., 2007;
Gla¨ser et al., 2009; Harder et al., 2010), and this expression
change was correlated with DNA hypermethylation of a single
CpG within S100A5, indicating a potential coregulatory
mechanism through methylation. S100A8 and S100A9 are
frequently coexpressed and preferentially form heterodimers
with each other. Both proteins are stress-induced and
overexpressed after epidermal injury (reviewed in: Kerkhoff
et al., 2012). S100A7 and S100A15, which are overexpressed
in psoriasis, exert antimicrobial activity and act as amplifiers
of inflammation through their chemotactic activity and the
T
ab
le
3
.
(C
o
n
ti
n
u
ed
)
A
N
ve
rs
u
s
N
N
M
et
h
yl
at
io
n
Ex
p
re
ss
io
n
C
p
G
ID
C
h
r
P
o
si
ti
o
n
h
g1
9
G
en
e
C
p
G
lo
ca
ti
o
n
M
ed
ia
n
m
et
h
d
if
fe
re
n
ce
P
-v
al
u
e
T
ra
n
sc
ri
p
t
ID
C
h
r
P
o
si
ti
o
n
h
g1
9
G
en
e
Fo
ld
ch
an
ge
P
-v
al
u
e
r
P
cg
1
6
7
9
1
6
8
6
1
9
4
8
2
4
9
0
1
4
G
LT
SC
R
2
C
G
is
la
n
d

0
.1
1
5
0
.0
1
8
5
IL
M
N
_1
7
0
3
5
6
5
1
9
4
8
2
4
8
7
9
3
G
LT
SC
R
2
0
.7
4
0
.0
1
1
6
0
.6
0
0
0
.0
0
9
9
cg
0
8
2
6
0
8
9
1
2
0
4
4
5
1
8
8
0
2
C
T
SA
C
G
I
N
sh
o
re
0
.1
7
0
0
.0
4
6
0
IL
M
N
_1
7
1
9
2
8
6
2
0
4
4
5
1
9
6
8
3
C
T
SA
0
.6
9
0
.0
4
5
6
0
.6
4
5
0
.0
0
4
8
cg
0
8
2
6
0
8
9
1
2
0
4
4
5
1
8
8
0
2
C
T
SA
C
G
I
N
sh
o
re
0
.1
7
0
0
.0
4
6
0
IL
M
N
_1
7
7
3
3
8
9
2
0
4
4
5
2
7
3
9
9
P
LT
P
0
.5
8
0
.0
1
9
6
0
.7
8
3
1
.8
1

1
0

4
cg
1
9
0
6
7
7
3
0
2
0
4
4
5
1
8
8
2
4
C
T
SA
C
G
I
N
sh
o
re
0
.1
0
0
0
.0
4
0
1
IL
M
N
_1
7
7
3
3
8
9
2
0
4
4
5
2
7
3
9
9
P
LT
P
0
.5
8
0
.0
1
9
6
0
.6
0
6
0
.0
0
9
0
A
L
ve
rs
u
s
A
N
M
et
h
yl
at
io
n
Ex
p
re
ss
io
n
C
p
G
ID
C
h
r
P
o
si
ti
o
n
h
g1
9
G
en
e
C
p
G
lo
ca
ti
o
n
M
ed
ia
n
m
et
h
d
if
fe
re
n
ce
P
-v
al
u
e
T
ra
n
sc
ri
p
t
ID
C
h
r
P
o
si
ti
o
n
h
g1
9
G
en
e
Fo
ld
ch
an
ge
P
-v
al
u
e
r
P
cg
0
1
5
6
8
7
3
6
1
8
6
1
4
4
1
7
3
0
SE
R
P
IN
B
7
In
tr
o
n
ic
0
.1
4
9
0
.0
0
5
5
IL
M
N
_1
7
0
3
8
5
5
1
8
6
1
3
2
2
4
3
1
SE
R
P
IN
B
3
7
.3
2
8
.8
5

1
0

4
0
.9
0
5
0
.0
0
4
6
cg
2
3
1
8
5
2
6
2
2
1
4
5
1
3
7
5
4
4
P
D
X
K
C
G
I
N
sh
o
re
0
.1
0
5
8
.5
8

1
0

4
IL
M
N
_1
7
6
1
7
9
7
2
1
4
5
1
9
2
3
9
3
C
ST
B
2
.3
9
0
.0
0
7
2
0
.8
7
4
0
.0
0
4
5
A
b
b
re
vi
at
io
n
s:
A
L,
A
D
le
si
o
n
al
;
A
N
,
A
D
n
o
n
-l
es
io
n
al
;
C
G
I,
C
p
G
is
la
n
d
;
C
h
r,
ch
ro
m
o
so
m
e;
N
N
,
co
n
tr
o
l
h
ea
lt
h
y.
E Rodrı´guez et al.
Analysis of AD-Associated DNA Methylation
www.jidonline.org 1879
induction of immunotropic cytokine expression in
keratinocytes (Wolf et al., 2011; Hegyi et al., 2012).
Similarly, our observations confirm increased levels of
KRT6A and KRT6B mRNA in AL skin (Sugiura et al., 2005;
Jarzab et al., 2010). This overexpression of both
KRT6A and KRT6B mRNA (AL versus NN: PKRT6A:expr
¼ 7.54 106, PKRT6B.1:expr¼1.25 104; AL versus AN:
PKRT6A:expr¼0.0038, PKRT6B.1:expr¼ 0.0004) was correlated
with decreased methylation of a single CpG in KRT6A. Both
keratins belong to the group of so-called alternative pathway
keratins. This alternative keratinization pathway is supposed to
provide a physiological response if rapid epidermal
regeneration processes are needed, e.g., in epidermal wound
healing after injury (Takahashi et al., 1995). Mutations in
KRT6A and KRT6B cause pachyonychia congenita, a rare
autosomal dominant skin disorder characterized by cytolysis
and hyperkeratosis (McLean et al., 2011).
Differential single CpG methylation coupled with altered
co-expression was also observed for OAS1, OAS2, and OAS3,
which belong to a family of proteins regulated by IFN and
are involved in the innate immune response to viral infection
(Bin et al., 2011). Further, methylation levels at a CpG
(cg06641366) located near LRRC8C (1p22.2) revealed a
strong positive correlation (r¼0.84, Pcorr¼2.0810–6) with
expression probes in trans for CD36 (7q21.11). CD36 has
been shown to be upregulated upon skin barrier disruption
(Schmuth et al., 2005) and in inflammatory skin disorders
(Westergaard et al., 2001, 2003; Fujimoto et al., 2010), to
mediate the secretion and processing of epidermal
lipoproteins (Schmuth et al., 2005) and to influence terminal
keratinocyte differentiation (Westergaard et al., 2003).
Together, these findings indicate altered methylation and
expression of genes important for keratinocyte differentiation,
proliferation, and innate immune response in lesional epider-
mis of AD patients.
Our study on AD yielded a lower number of DMS as
compared with a previous epigenome-wide association study
on psoriasis skin (Roberson et al., 2011). Apart from
differences in study design, this might reflect a higher degree
of heterogeneity in terms of disease phenotype and patho-
physiology. However, it is noteworthy that from the top 50
DMS reported for lesional psoriatic versus healthy control skin
(Roberson et al., 2011) a total of 19 CpGs showed significant
and analogous differential methylation in lesional AD versus
healthy control epidermis (Supplementary Table S7 online).
For example, as for psoriasis, we observed a hypomethylation
of the CG dinucleotide cg20161089 in IFI27 and adjacent
sites, which was accompanied by significantly increased
mRNA expression in AL as compared to NN (Supplementary
Figure S7 online and Supplementary Table S8 online). IFI27
belongs to the family of IFN-stimulated genes, which mediate
antiviral effects (Schoggins and Rice, 2011). It is upregulated
in psoriatic skin and is supposed to be involved in keratinocyte
hyperproliferation in skin cancer, psoriasis, and chronic
eczema (Suomela et al., 2004).
These findings support the results from genetic association
studies, which indicate the presence of shared risk loci
between AD and psoriasis (Weidinger et al., 2013).
Our study suffers from several limitations, such as small
sample sizes, lack of independent replication, and application
of low coverage platforms. Further, although an in-silico
mQTL analysis in blood from a large population-based cohort
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Figure 1. Heat map showing in-cis regulated mRNA expression in AD lesional (AL) versus control healthy (NN). The left column indicates cases in black and
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did not observe any single-nucleotide polymorphism associa-
tion with methylation levels at our top DMS within a distance
of 500kb (Petersen et al., 2013), we cannot fully exclude
influences of low-prevalent genetic variations in the epidermis
and the context of AD. However, the tissue specificity and the
lack of ‘‘outliers’’ for methylation levels at the sites we report
render this possibility very unlikely. It should also be noted
that our results do not allow conclusions on whether the DNA
methylation changes between AD and healthy epidermis are a
marker of predisposing causal mechanisms or mediators of
causal environmental influences or simply a consequence of
the disease or disease-associated features.
Finally, advanced studies will have to investigate the
detailed functional consequences of aberrant methylation at
the sites we report.
However, we feel that, at large, our approach provides
evidence for functionally relevant differences in DNA methy-
lation, in particular in the epidermis, which are associated
with AD, and that it represents a starting point in the field of
epigenetic epidemiology in complex skin diseases.
MATERIALS AND METHODS
Study cohort and sample preparation
The study was conducted according to the Declaration of Helsinki
Principles and after written informed patient consent in accordance
with local ethical committee approval. In all, 28 patients suffering
from dermatologist-diagnosed AD and 29 healthy volunteers without
a self-reported history of atopic diseases (asthma, AD, rhinitis) were
recruited through Dermatology Departments at University Hospitals
in Munich and Bonn. All patients suffered from moderate to severe
early-onset persistent disease, received no systemic treatment at the
time of sampling, and skin lesions chosen for biopsy had not been
treated topically for at least 48hours. Epidermal shaves of approxi-
mately 36mm2 from lesional and non-lesional skin (patients) and
from healthy skin (controls) were taken and immediately stored in
PAXgene Tissue Tubes (Qiagen, Hilden, Germany) at  80 1C until
further processing. DNA and RNA were extracted with the QIAamp
DNA Mini Kit (Tissue Protocol; Qiagen) and the PAXgene Tissue RNA
Kit (Qiagen), respectively.
Whole blood samples were taken for DNA extraction and for
isolation of CD4þ T cells and B cells. After peripheral blood mono-
nuclear cell isolation by density gradient centrifugation (Ficoll-Paque),
both cell types were purified by negative selection using the MACS
CD4þ T-Cell Isolation Kit and the MACS B Cell Isolation Kit II (Miltenyi
Biotec, Bergisch Gladbach, Germany). Approximately 1 107cells
were resuspended in 200ml phosphate-buffered saline and stored in
liquid nitrogen until DNA was extracted with the QIAamp DNA Mini
Kit (Blood or Body Fluid Spin Protocol, Qiagen). A 9-ml EDTA tube of
peripheral blood was subjected to DNA isolation using a slightly
modified protocol based on the study by Miller et al. (1988).
All protocols for storage and isolation of nucleic acids as well as for
purification of T cells and B cells were applied following the
manufacturer’s instructions (Qiagen and Miltenyi Biotec).
DNA and RNA qualities were assessed on a 0.8% agarose gel after
electrophoresis and a NanoDrop 8000 (Thermo Fisher Scientific,
Schwerte, Germany) or with the RNA 6000 Nano Kit on the
Bioanalyzer 2100 (Agilent Technologies, Bo¨blingen, Germany). Only
DNA samples providing a compact band X20.000bp and an OD
ratio 260/280 of X1.7, and RNA samples with a RNA integrity
number X6 and an OD ratio 260/280 of X1.9 were subjected to
downstream analysis.
Infinium 27K methylation assay
DNA methylation status for the different tissue samples was deter-
mined using the Infinium Human Methylation27 BeadChip (Illumina,
San Diego, CA). In brief, genomic DNA (700ng) from each sample
was bisulfite converted with the EZ DNA Methylation or the EZ-96
DNA Methylation Kit (Zymo Research, Irvine, CA). A 250ng quantity
of converted DNA was subjected to the Illumina Infinium methylation
assay and hybridized on BeadChips. Raw data processing and initial
quality visualization were performed with the Illumina GenomeStu-
dio (version 2011.1) Methylation Module software (version 1.9.0,
Illumina). For data normalization, we used the pipeline described in
the study by Touleimat and Tost (2012) adapted for the Illumina 27k
Methylation Chip with default parameter settings. In brief, after
excluding samples with more than 20% of bad quality probes
(detection P-valueo0.01) and CpG sites (n¼ 846) in close
proximity (50bp) to common single-nucleotide polymorphisms
(source:1kg.eur.hg19), for each chip background level correction
and color bias adjustment were performed using the Bioconductor
lumi package (Du et al., 2008). Normalization between samples was
applied by building categories using the ‘‘relation to CpG-island’’
information (i.e., south shore, south shelf, north shore, north shelf,
and distant) from the Illumina annotation file. For statistical analysis,
25,648 b-values with a detection P-value o0.01 were considered.
HumanHT-12 Expression BeadChip
Whole-genome expression profiles for AL, AN, and NN samples were
generated with the Illumina HumanHT-12 v3 Expression BeadChip
(Illumina). RNA amounting to 500ng was first reverse transcribed into
complementary DNA. After second strand synthesis and purification
of cDNA, in vitro transcription into cRNA and biotin-UTP labeling
were performed using the Illumina TotalPrep-96 RNA Amplification
Kit (Ambion, Life Technologies, Carlsbad, CA). RNA amounting to
3000ng was hybridized to the Illumina HumanHT-12 v3 Expression
BeadChip. Chips were washed, detected, and scanned according to
the manufacturer’s instructions. Data collection and visualization
were performed with the Illumina GenomeStudio 2011.1 Gene
Expression Module software.
Sequenom EpiTyper assay
Sequenom matrix-assisted laser desorption/ionization–time-of-flight
EpiTyper assay (Sequenom, San Diego, CA) was used for technical
validation and fine mapping of 24 single CpGs at 23 different
genomic loci as selected from the screen. Assays were designed with
the EpiDesigner BETA software (http://www.epidesigner.com/) as
provided by Sequenom. All assays were designed so as to cover all
24 CpGs identified in the screen and a maximum of CpGs within an
approximately 400bp region. Primer sequences for bisulfite-treated
genomic DNA can be found in Supplementary Table S9 online.
A 700-ng quantity of genomic DNA from each sample was bisulfite
converted with the EZ DNA Methylation Kit (Zymo Research) accord-
ing to the manufacturer’s recommendations. Quantitative methylation
measurement was carried out by matrix-assisted laser desorption/
ionization–time-of-flight mass spectrometry using the EpiTYPER Mass-
ARRAY (Sequenom) as previously described (Ehrich et al., 2005).
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Quality control for the EpiTyper assay included double measurement
of amplicon 2 containing six CpG sites in all samples, which showed
high concordance. Testing of bisulfite conversion rates was applied
using the bioconductor package MassArray (Thompson et al., 2009).
Samples showing a conversion rateo80% were excluded from analysis.
Analysis of DNA methylation standards of 0%, 25%, 50%, and 100%
yielded a good calibration line (Supplementary Figure S8 online).
For person- and CpG-wise call rate, a threshold of 80% was applied.
Technical validation with the EpiTyper was conducted in 21 AL, 10
AN, and 24 NN samples, from whom DNA was still available.
Reverse-transcriptase–qPCR
For technical validation of mRNA expression differences of selected
genes qPCR was applied. The same RNA samples used for the Human
HT-12 Expression BeadChip were reverse transcribed and subjected
to qPCR using a StepOne Real-Time PCR System (Applied Biosystem,
Carlsbad, CA) as described previously (Roth et al., 2013). The specific
primer sequences for the different genes can be found in
Supplementary Table S10 online. Standard curves were generated
for each primer set using serial dilutions of complementary DNA.
Relative mRNA expression levels were normalized to expression of
the housekeeping genes, human acidic ribosomal protein (hARP) and
ribosomal protein L38 (RP38). Both standardized measurements were
used to compare 10 AL with 12 NN as well as 9 AL/AN pairs using
the nonparametric Wilcoxon signed rank test and the paired t-test.
We found strong concordance between HT-12 expression mea-
surement and qPCR except for TBX6, CD248, and CCND1
(Supplementary Table S11 online). Moreover, the five most strongly
altered mRNA expression levels on the HT-12 chip exhibited similar
P-values in the qPCR with the same direction of expression differ-
ences between AL and NN.
Statistical analysis
Quality of preprocessed data, b-values, with the pipeline described in
the study by Touleimat and Tost (2012) was assessed by
multidimensional scaling plots clustering samples by tissue and sex.
b-Values represent the ratio of the intensity of the methylated bead
type of the combined locus intensity and are intuitively interpreted.
DNA methylation data were normalized within and between chips
using quantile normalization.
In addition, we used two standard DNAs from a control sample
(blood, epidermal sheet) for assessing the experiment’s reliability.
Pearson correlation across all CpGs was high (r40.98). Finally,
b-values of the replicated sample were averaged for differential
DNA methylation analysis assessed using median regression adjusted
for age and sex implemented in the quantreg package (Koenker,
2012). As the biological impact of small changes in DNA methylation
on gene expression is unknown, we decided to use a threshold of
10% median methylation difference between sample groups in order
to assure functional relevance. For multiple testing adjustment, the
Bonferroni or false discovery rate method (Benjamini and Hochberg,
1995) was applied.
For expression analysis, the raw data were exported from the
Illumina ‘‘GenomeStudio’’ Software to R. The data were converted
into logarithmic scores and normalized using the quantiles method
(Du et al., 2008). Differences in expression levels between cases and
controls were compared using linear regression models that were
adjusted for age and sex.
For comparison of DNA methylation and expression data within
the same individual, the t-test for paired samples was applied.
Functional integration was assessed by in-cis correlation of sig-
nificant DMS and DETs within a 200-kb interval between probes
using thresholds of spearman correlation |r|40.5, Po0.01. For in-
trans correlation of significant DMS and DETs, we required a more
stringent rank correlation of |r|40.8 and considered only significan-
tly differentially expressed genes below a Bonferroni threshold of
1.5 10 5.
Functional enrichment analyses were performed with DAVID
(Huang da et al., 2009a, b) using the following settings: uploaded
gene lists displayed the official gene symbol; annotations were limited
to Homo sapiens; DAVID default Homo sapiens whole-genome
background and pre-built Illumina HumanHT-12_V3 array
background were used for clustering of DMS and DET gene
annotations. We display Benjamini–Hochberg corrected P-values
(PBH).
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